We're going to have Prurisol results in 1Q or early 2Q 2017. Everything has looked so good for it in the earlier clinical trial -- good response rate at a dose that's less than what they're doing in the current trial, far fewer side effects than current drugs -- and the company is doing it at 25 sites to speed the trial up, so this is a big sign that they're confident the results are going to be great.

Prurisol alone could send the stock price up to 10x where it is now (and that's being very conservative with the projection). So yes, I think this is finally the year that we get the first huge jump up in stock price. Not investment advice, of course